Search results
The FDA Could, Finally, Approve Novavax's Covid Vaccine — Is Novavax Stock A Buy?
Investor's Business Daily· 2 days agoNovavax will also receive tiered royalties on sales. Sanofi also made a $70 million investment in...
Another COVID vaccine? Yes, and here’s why
Denver Post· 4 days agoVaccine manufacturers Pfizer and Moderna say they were prepared to make updated vaccines available in August, pending final FDA approval ...
Two shots in one? Moderna's COVID-19 and flu vaccine reports favorable results
USA Today· 6 days agoModerna said Monday that its combination vaccine against flu and COVID-19 drew a greater immune...
FDA asks COVID vaccine makers to target KP.2 strain, if feasible, for next shot
Reuters via AOL· 1 day agoThe Food and Drug Administration's change in recommendation, in an update dated Thursday, comes even...
3 High-Yield S&P 500 Dividend Stocks Down More Than 25% to Buy Now and Hold for at Least a Decade |...
The Motley Fool· 7 hours agoShares of Pfizer are down about 31% over the past 12 months. The pharmaceutical company's...
FDA recommends COVID jab manufacturers update formulas to combat new strain
BizPac Review· 14 hours agoThe U.S. Food and Drug Administration (FDA) announced Thursday that manufacturers of the COVID vaccines should focus on the KP.2 strain of the JN.1 variant ...
Combined flu and Covid vaccine from Moderna shows positive trial results
PA Media: Science via Yahoo News· 6 days agoA spokesman for Moderna said they hoped the jab would be available for the 2025 or 2026 flu season....
Moderna sees positive results in COVID-flu vaccine trial
The Hill· 6 days agoThe combination vaccine, which Moderna calls mRNA-1083, produced a higher immune response than...
Pfizer: An Oversold Pharma Stock in Recovery
GuruFocus.com via Yahoo Finance· 4 days agoThis combination caused a mechanical reaction of profit squeeze, which is unlikely to be sustained as inflation stabilizes and Pfizer's revenue sources...
Moderna's (MRNA) Next-Gen COVID-19 Jab Study Meets Efficacy Goal
Zacks via Yahoo Finance· 23 hours agoData from a late-stage study shows that Moderna's (MRNA) next-generation COVID-19 vaccine achieved...